Literature DB >> 26197237

Downregulation of SKA1 Gene Expression Inhibits Cell Growth in Human Bladder Cancer.

Feng Tian1, Xiaoxiao Xing1, Feng Xu1, Wen Cheng1, Zhengyu Zhang1, Jianping Gao1, Jingping Ge1, Hailong Xie2.   

Abstract

Spindle and kinetochore-associated protein 1 (SKA1), a component of microtubule-binding complex of kinetochore, is essential for proper chromosome segregation. Recently, SKA1 has been shown to be involved in malignant progression of several human cancers. However, its role in bladder cancer is still unknown. To evaluate the function of SKA1 in bladder cancer cells, the authors employed an RNA interference lentivirus system to deplete its expression in both BT5637 and T-24 bladder cancer cells. The cell proliferation was significantly decreased in both cell lines after SKA1 knockdown. Moreover, the colony formation capacity was impaired by SKA1 silencing. Flow cytometry analysis showed that depletion of SKA1 led to cell cycle arrest at S phase. Furthermore, knockdown of SKA1 in T-24 cells obviously downregulated the expressions of CDK4 and Cyclin D1, and alleviated the activations of ERK2 and AKT, conducive to cell growth inhibition. These findings suggested that knockdown of SKA1 could potently suppress bladder cancer cell proliferation in vitro and lentivirus-mediated silencing of SKA1 might serve as a novel strategy for gene therapy of bladder cancer.

Entities:  

Keywords:  RNA interference; SKA1; bladder cancer; cell growth

Mesh:

Substances:

Year:  2015        PMID: 26197237     DOI: 10.1089/cbr.2014.1715

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  8 in total

1.  Identification of Spindle and Kinetochore-Associated Family Genes as Therapeutic Targets and Prognostic Biomarkers in Pancreas Ductal Adenocarcinoma Microenvironment.

Authors:  Yi Liu; Zong-Rui Jin; Xing Huang; Ye-Cheng Che; Qin Liu
Journal:  Front Oncol       Date:  2020-11-02       Impact factor: 6.244

2.  SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer.

Authors:  Lihua Shen; Min Yang; Qionghua Lin; Zhongwei Zhang; Changhong Miao; Biao Zhu
Journal:  Oncol Rep       Date:  2016-03-10       Impact factor: 3.906

3.  Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.

Authors:  Takayuki Arai; Atsushi Okato; Satoko Kojima; Tetsuya Idichi; Keiichi Koshizuka; Akira Kurozumi; Mayuko Kato; Kazuto Yamazaki; Yasuo Ishida; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  Cancer Sci       Date:  2017-08-19       Impact factor: 6.716

4.  Anti-tumor roles of both strands of the miR-455 duplex: their targets SKA1 and SKA3 are involved in the pathogenesis of renal cell carcinoma.

Authors:  Yasutaka Yamada; Takayuki Arai; Satoko Kojima; Sho Sugawara; Mayuko Kato; Atsushi Okato; Kazuto Yamazaki; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  Oncotarget       Date:  2018-06-01

5.  Identification of biomarkers of chromophobe renal cell carcinoma by weighted gene co-expression network analysis.

Authors:  Xiaomao Yin; Jianfeng Wang; Jin Zhang
Journal:  Cancer Cell Int       Date:  2018-12-17       Impact factor: 5.722

6.  SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.

Authors:  Yibing Chen; Jingjing Zhao; Zhihui Jiao; Weiwei Wang; Dandan Wang; Xiaohe Yu; Zhiyong Shi; Naijian Ge; Qiuzhong Pan; Jianchuan Xia; Wancheng Niu; Ruihua Zhao; Xiaofei Zhang; Wei Du
Journal:  BMC Cancer       Date:  2018-12-11       Impact factor: 4.430

7.  SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways.

Authors:  Xizhao Wang; Yu Zeng; Mingfeng Zhou; Xian Zhang; Anqi Xu; Jie Lin; Zhiyong Wu; Cheng Xie; Jie Luo; Shengfeng Ding; Zhengming Zhan; Hao Long; Ye Song
Journal:  Cancer Cell Int       Date:  2019-12-03       Impact factor: 5.722

8.  Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway.

Authors:  Ye Yao; Xiaoqin Li; Lihua Cheng; Xiuhua Wu; Bobo Wu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.